Scholar Rock Holding Corp logo

Scholar Rock Holding Corp

STU:2QK (USA)  
€ 13.60 (-0.73%) Mar 15
At Loss
P/B:
4.85
Market Cap:
€ 958.06M ($ 1.04B)
Enterprise V:
€ 815.49M ($ 886.50M)
Volume:
250.00
Avg Vol (2M):
394.00
Also Trade In:
Volume:
250.00
At Loss
Avg Vol (2M):
394.00

Business Description

Description
Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company primarily operates in the United States. The company's lead product candidate is Apitegroma which is a highly selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGF?1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.
Name Current Vs Industry Vs History
Cash-To-Debt 3.44
Equity-to-Asset 0.67
Debt-to-Equity 0.38
Debt-to-EBITDA -0.4
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 24.25
9-Day RSI 36.42
14-Day RSI 41.85
6-1 Month Momentum % 150.43
12-1 Month Momentum % 49.22

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.55
Quick Ratio 8.55
Cash Ratio 8.18

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.1
Shareholder Yield % 0.29

Financials (Next Earnings Date:2024-05-09 Est.)

STU:2QK's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Scholar Rock Holding Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 31.334
EPS (TTM) (€) -1.823
Beta 1.49
Volatility % 97.96
14-Day RSI 41.85
14-Day ATR (€) 0.657763
20-Day SMA (€) 14.59
12-1 Month Momentum % 49.22
52-Week Range (€) 5.35 - 18.4
Shares Outstanding (Mil) 72.14

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Scholar Rock Holding Corp Filings

Filing Date Document Date Form
No Filing Data

Scholar Rock Holding Corp Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Scholar Rock Holding Corp Frequently Asked Questions

What is Scholar Rock Holding Corp(STU:2QK)'s stock price today?
The current price of STU:2QK is €13.60. The 52 week high of STU:2QK is €18.40 and 52 week low is €5.35.
When is next earnings date of Scholar Rock Holding Corp(STU:2QK)?
The next earnings date of Scholar Rock Holding Corp(STU:2QK) is 2024-05-09 Est..
Does Scholar Rock Holding Corp(STU:2QK) pay dividends? If so, how much?
Scholar Rock Holding Corp(STU:2QK) does not pay dividend.

Press Release

Subject Date
No Press Release